When you develop life-saving drugs, you have serious skin in the game. 3M’s hMTS System is designed to help your biologic formulation push past barriers, and reach its intended destination.
It’s time to approach clinical trials with confidence. We have a device designed to consistently and reproducibly deliver your cancer vaccine to the patient’s dermis. 3M Hollow Microstructured Transdermal System (hMTS) is designed to help your biologic formulation break through skin barriers and potentially achieve your clinical objectives.
In leading up to the finalized 3M Hollow Microstructured Transdermal System design. 3M has applied a rigorous process including:
While drug PK profiles need to be evaluated on an individual basis, microneedle delivery via 3M™ Hollow Microstructured Delivery System may offer potential benefits when compared with conventional injections2:
2 3M, data on file.
Product in development. Not available for commercial sale.